Company: SLMT
Filing Date: 2025-05-28
Form Type: 20-F/A
Source: 0001213900-25-048029
Chunk: 4

Company: Brera Holdings PLC
Filing Date: 2025-05-28
Form: 20-F/A
Chunk 4
---
 |    1 |
| 5.B.     |     | Liquidity and Capital Resources                            |    7 |
| 5.C.     |     | Research and Development, Patents and Licenses, etc.       |   11 |
| 5.D.     |     | Trend Information                                          |   11 |
| 5.E.     |     | Critical Accounting Estimates                              |   11 |
| Item 11. |     | Quantitative and Qualitative Disclosures About Market Risk |   12 |
|          |     | PART III                                                   |      |
| Item 17. |     | Financial Statements                                       |   14 |
| Item 18. |     | Financial Statements                                       |   14 |
| Item 19. |     | Exhibits                                                   |   14 |

i ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated financial statements and the related notes included elsewhere in this Annual Report. This discussion may contain forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements because of various factors, including those set forth under “Item 3. Key Information—D. Risk Factors” or in other parts of this Annual Report. See also “Introductory Notes—Forward-Looking Information.” 5.A. Operating Results The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) of Brera Holdings summarizes the significant factors affecting the Company’s operating results, financial condition, liquidity and cash flows as of and for the years ended December 31, 2024 and 2023. Certain information called for by this Item 5, including a discussion of the year ended December 31, 2023 compared to the year ended December 31, 2022 has been reported previously in our Annual Reporton Form 20-F for the year ended December 31, 2023, under the section entitled “ Item 5. Operating and Financial Review and Prospects—A. Operating Results—Results of Operations—Comparison of the Years December 31, 2023 and 2022.” This MD&A should be read in conjunction with the Company’s consolidated financial statements and the related notes thereto for the year ended December 31, 2024 (the “2024 Financials”). Amounts are expressed in euros unless otherwise stated. This MD&A contains forward-looking statements